PDSB 10-Q: SEC filing
PDS Biotechnology
Filed with the SEC on · accession 0001140361-26-043844
PDSB filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +5.9% by the first close after the filing.
Summary of the filing
PDS Biotechnology filed its quarterly 10-Q for the period ended September 30, 2026, reporting a net loss and a decline in cash and cash equivalents to $15.2 million from $26.7 million at year-end 2025, with no debt outstanding.
Key details
How PDSB stock reacted
Close before
$0.87
Nov 13, 2026
First close after
+5.90%
$0.92
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PDSB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PDSB?
Click hereFrequently asked questions
What did PDSB file with the SEC on Nov 16, 2026?
PDSB filed a 10-Q (SEC filing). PDS Biotechnology filed its quarterly 10-Q for the period ended September 30, 2026, reporting a net loss and a decline in cash and cash equivalents to $15.2 million from $26.7 million at year-end 2025, with no debt outstanding.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did PDSB stock react to this filing?
PDSB closed at $0.87 before the filing and $0.92 on Nov 16, 2026 (+5.90%).
Other PDSB SEC filings
- 8-K · SEC filingNov 13, 2026
- SCHEDULE 13D/A · Board changeNov 12, 2026
- 8-K · SEC filingNov 10, 2026
- 8-K · SEC filingOct 21, 2026
- 8-K · Board changeOct 20, 2026
- S-3 · Shelf registrationOct 14, 2026
- 8-K · SEC filingOct 6, 2026
- 8-K · Fda approvalSep 22, 2026
- 8-K · SEC filingSep 21, 2026
- 8-K · Board changeSep 14, 2026
Get alerts when PDSB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days